GCCL Introduces Next-Generation Immune Cell Analyzer, Strengthening Advanced Biopharma Analysis
AI 요약 정보
- GCCL first Korean trial analysis company to adopt BD FACSDiscover A7
- Analyzer uses more than 50 markers to assess immune cells
- GCCL plans analysis services for advanced biopharmaceuticals